Anaeropharma Science will present its latest research outcomes regarding bispecific antibody producing recombinant Bifidobacterium at the 2020 Annual Meeting of the AACR

Anaeropharma Science will present its latest research outcomes towards bispecific antibody producing recombinant Bifidobacterium at the 2020 Annual Meeting of the AACR (American Association for Cancer Research) that will virtually take place during June 22-24, the poster is titled Anti-tumor activity of Bifidobacterium secreting dual specific T cell redirecting antibody against EGFR/HER3-expressing cancer”.

Comments are closed.